Other related webinars
New FDA requirements: Recent changes to FDA requ...
Friday, 10th February, 2012
Time : 02:00 PM EST | 11:00 AM PST
Assessing off-label drug use after approval : re...
Friday, 9th March, 2012
Time : 02:00 PM EST | 11:00 AM PST
Reducing risk of international drug development ...
Wednesday, 11th April, 2012
Time : 02:00 PM EST | 11:00 AM PST
Use of risk management plans for integrated bene...
Thursday, 14th June, 2012
Time : 02:00 PM EST | 11:00 AM PST
FDA requirements for Risk Evaluation and Managem...
Friday, 29th June, 2012
Time : 02:00 PM EST | 11:00 AM PST
Enterprise Project Portfolio Management - Moving...
Friday, 12th October, 2012
Time : 02:00 PM EST | 11:00 AM PST
The new concept of Effective Risk Management : A...
Friday, 26th October, 2012
Time : 02:00 PM IST | 09:30 AM CET
Managerial Decision-Making Under Risk and Uncert...
Wednesday, 21st November, 2012
Time : 02:00 PM EST | 11:00 AM PST
Crossing the chasm from Traditional Project Man...
Friday, 7th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
Risk assessment: approaches to avoid medication ...
Monday, 24th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
Risks of not achieving comparability of biologic...
Friday, 18th January, 2013
Time : 02:00 PM EST | 11:00 AM PST
Risk Analysis & Risk Assessment in Drug Discover...
Monday, 4th February, 2013
Time : 02:00 PM EST | 11:00 AM PST
Building A Successful and Sustainable PMO
Friday, 8th February, 2013
Time : 02:00 PM EST | 11:00 AM PST
Achieving the lifecycle approach to process vali...
Wednesday, 20th March, 2013
Time : 02:00 PM EST | 11:00 AM PST
Risk Based Approach to the Management and Monito...
Friday, 3rd May, 2013
Time : 02:00 PM EST | 11:00 AM PST
How to Write a Scientific Article
Friday, 5th June, 2015
Time : 11:00 AM EST | 05:00 PM CET
The New Pipeline Physics Model : Manage pipeline...
Friday, 23rd October, 2015
Time : 01:00 PM EDT | 10:00 AM PDT
EMA & US FDA view of regulatory aspects of pha...
Friday, 19th February, 2016
Time : 01:00 PM EDT | 10:00 AM PDT
FDA and Safety Monitoring
Friday, 15th July, 2016
Time : 01:00 PM EDT | 10:00 AM PDT
Panel Discussion on Quality Management Principle...
Monday, 20th February, 2017
Time : 04:00 PM IST | 11:30 AM BST
Back to the basics: Refresh your epidemiology kn...
Friday, 17th July, 2020
Time : 121:00 PM EST | 10:00 AM PST
2021 Guidelines for Office and Outpatient Visits...
Friday, 8th January, 2021
Time : 01:00 PM EDT | 10:00 AM PDT
Latest News
Monday, 12th April, 2021
Time : |
Recorded Webinar
Enterprise Project Portfolio Management - Moving Beyond Value Creation To Value Maximization
timelapse 60 mins with 10-15 mins of Q and A
Note:
This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times
Speaker/Presenter
Short Abstract
To many of us, Portfolio Management is a logical extension of Project Management. Yet, we cannot apply exactly the same principles to Portfolio Management as we do to Project Management. So, how do we maximize the value of a portfolio consisting of many projects (and programs) subject to constrained budgetary and human resources on an ongoing basis?
A classic technique used to manage a portfolio of projects (and programs) is to prioritize such assets on one or more quantitative (e.g. NPV) and qualitative (e.g. strategic value) criteria and to ‘draw the line’ when one or other resource runs out. But, how do we know that the sum of all projects ‘above the line’ represents the highest value that can be created i.e. the best utilization of those resources? And, how do we determine portfolio value that is left on the proverbial table? To better understand how constrained budgetary and human resources can be best utilized in a portfolio of non-discretionary and discretionary assets, a new Portfolio Management framework - CREOPMTM - is described.
CREOPMTM is a robust framework that represents a sequential process of Project Categorization, Risk Analysis, Integrated Evaluation, Portfolio Optimization, Project Prioritization, and Portfolio Management. This framework has been applied successfully across multiple industries that include Pharmaceuticals & Biotechnology, Consumer Goods, and Healthcare Risk Insurance and, by definition, is utilized in both highly innovative and less innovative pipeline environments. It has also been utilized successfully within the IT sector across several industries.
Who should attend
Biotech and Pharma companies/professionals including :
- Business Development
- Product Development
- Project Management
- Regulatory affairs
- Sales and Marketing
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.